221 related articles for article (PubMed ID: 38454994)
1. A review of the clinical characteristics and management of immunosuppressed patients living with HIV or solid organ transplants infected with SARS-CoV-2 omicron variants.
Song Y; Lou L; Zhang K
Front Public Health; 2024; 12():1327093. PubMed ID: 38454994
[TBL] [Abstract][Full Text] [Related]
2. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 Disease in Pediatric Solid Organ Transplantation from Alpha to Omicron: A High Monocyte Count in the Preceding Three Months Portends a Risk for Severe Disease.
Sirgi Y; Stanojevic M; Ahn J; Yazigi N; Kaufman S; Khan K; Vitola B; Matsumoto C; Kroemer A; Fishbein T; Ekong UD
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515245
[TBL] [Abstract][Full Text] [Related]
4. Is the Omicron variant truly less virulent in solid organ transplant recipients?
Anjan S; Khatri A; Viotti JB; Cheung T; Garcia LAC; Simkins J; Loebe M; Phancao A; O'Brien CB; Sinha N; Ciancio G; Vianna RM; Andrews D; Abbo LM; Guerra G; Natori Y
Transpl Infect Dis; 2022 Dec; 24(6):e13923. PubMed ID: 35915957
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes.
Wong G; Rowlandson M; Sabanayagam D; Ginn AN; Kable K; Sciberras F; Au E; Draper J; Arnott A; Sintchenko V; Dwyer DE; Chen SCA; Kok J
Transplantation; 2022 Sep; 106(9):1860-1866. PubMed ID: 35675438
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy.
Infante MS; Nemirovsky D; Devlin S; DeWolf S; Tamari R; Dahi PB; Lee YJ; Chung DJ; Politikos I; Barker J; Giralt SA; Babady NE; Ramanathan L; Papanicolaou GA; Seo S; Kamboj M; Perales MA; Shah GL
Transplant Cell Ther; 2024 Jan; 30(1):116.e1-116.e12. PubMed ID: 37806446
[TBL] [Abstract][Full Text] [Related]
7. Humoral immunity against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccine.
Saharia KK; Husson JS; Niederhaus SV; Iraguha T; Avila SV; Yoo YJ; Hardy NM; Fan X; Omili D; Crane A; Carrier A; Xie WY; Vander Mause E; Hankey K; Bauman S; Lesho P; Mannuel HD; Ahuja A; Mathew M; Avruch J; Baddley J; Goloubeva O; Shetty K; Dahiya S; Rapoport AP; Luetkens T; Atanackovic D
Clin Transl Immunology; 2022; 11(5):e1391. PubMed ID: 35505864
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Omicron infection in a cohort of hospitalized kidney transplant recipients: Risk factors of severity.
Cai Z; Wang T
Clin Nephrol; 2024 May; 101(5):238-249. PubMed ID: 38497686
[TBL] [Abstract][Full Text] [Related]
9. Wild-type SARS-CoV-2 neutralizing immunity decreases across variants and over time but correlates well with diagnostic testing.
O'Shea KM; Schuler CF; Chen J; Troost JP; Wong PT; Chen K; O'Shea DR; Peng W; Gherasim C; Manthei DM; Valdez R; Baldwin JL; Baker JR
Front Immunol; 2023; 14():1055429. PubMed ID: 36845123
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological characteristics of 17 imported patients infected with SARS-CoV-2 Omicron variant.
Liu X; Chen M; Zhou Z; Chen D; Mo J; Liu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):344-351. PubMed ID: 35545327
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.
Elens L; Langman LJ; Hesselink DA; Bergan S; Moes DJAR; Molinaro M; Venkataramanan R; Lemaitre F
Ther Drug Monit; 2020 Jun; 42(3):360-368. PubMed ID: 32304488
[TBL] [Abstract][Full Text] [Related]
12. [Analyze the clinical characteristics of mild and severe SARS-CoV-2 infected patients based on the local Omicron variant epidemic].
Yan Y; Lyu C; Davgadorj C; Wang X; Sha M
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jan; 35(1):32-36. PubMed ID: 36880235
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 BA.2 (Omicron) variant infection in pediatric liver transplanted recipients and cohabitants during 2022 Shanghai outbreak: a prospective cohort.
Zhu XY; Lu YF; Xue F; Luo Y; Feng MX; Qiu BJ; Zhou T; Zhu JJ; Zhang JJ; Wan P; Xia Q
Virol J; 2023 Feb; 20(1):28. PubMed ID: 36774503
[TBL] [Abstract][Full Text] [Related]
14. Difference between SARS-CoV-2, seasonal coronavirus, influenza, and respiratory syncytial virus infection in solid organ transplant recipients.
Mendoza MA; Motoa G; Raja MA; Frattaroli P; Fernandez A; Anjan S; Courel SC; Natori A; O'Brien CB; Phancao A; Sinha N; Vianna R; Loebe M; Ciancio G; Simkins J; Abbo L; Guerra G; Natori Y
Transpl Infect Dis; 2023 Feb; 25(1):e13998. PubMed ID: 36477946
[TBL] [Abstract][Full Text] [Related]
15. Insight into SARS-CoV-2 Omicron variant immune escape possibility and variant independent potential therapeutic opportunities.
Alam MS
Heliyon; 2023 Feb; 9(2):e13285. PubMed ID: 36744070
[TBL] [Abstract][Full Text] [Related]
16. Vaccine Effectiveness Against the SARS-CoV-2 B.1.1.529 Omicron Variant in Solid Organ and Islet Transplant Recipients in England: A National Retrospective Cohort Study.
Callaghan CJ; Curtis RMK; Mumford L; Whitaker H; Pettigrew G; Gardiner D; Marson L; Thorburn D; White S; Parmar J; Ushiro-Lumb I; Manas D; Ravanan R;
Transplantation; 2023 May; 107(5):1124-1135. PubMed ID: 36727724
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies.
Goldman JD; Robinson PC; Uldrick TS; Ljungman P
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34117116
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 in Solid Organ Transplantation: A Matched Retrospective Cohort Study and Evaluation of Immunosuppression Management.
Miarons M; Larrosa-García M; García-García S; Los-Arcos I; Moreso F; Berastegui C; Castells L; Pérez-Hoyos S; Varela J; Pau-Parra A; Varón-Galcera C; Parramon-Teixidó CJ; Martínez-Casanova J; Domènech L; García-Ortega P; Sánchez-Sancho P; Alonso-Martínez C; Gómez-Ganda L; Roch-Santed M; Gracia-Moya A; Del-Rio-Gutiérrez JM; Guillén-Del-Castillo A; Sans-Pola C; Antón A; Montoro B; Gorgas-Torner MQ;
Transplantation; 2021 Jan; 105(1):138-150. PubMed ID: 32941394
[TBL] [Abstract][Full Text] [Related]
19. Impact of Vaccination and Early Monoclonal Antibody Therapy on Coronavirus Disease 2019 Outcomes in Organ Transplant Recipients During the Omicron Wave.
Solera JT; Árbol BG; Alshahrani A; Bahinskaya I; Marks N; Humar A; Kumar D
Clin Infect Dis; 2022 Dec; 75(12):2193-2200. PubMed ID: 35445690
[TBL] [Abstract][Full Text] [Related]
20. Severity of SARS-CoV-2 Omicron variant infection in heart transplant recipients.
Hazan F; Verdonk C; Coutance G; Ferré VM; Marot S; Melo VDD; Legeai C; Lebreton G; Para M; Varnous S; Dorent R
J Heart Lung Transplant; 2023 May; 42(5):558-561. PubMed ID: 36822931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
